IHS Chemical Week

World News and Views :: Top of the News

Sun Pharma to acquire Ranbaxy for $3.2 billion

5:51 AM MDT | April 7, 2014 | Deepti Ramesh

Sun Pharmaceutical Industries (Mumbai) says it has agreed to acquire 100% of Ranbaxy Laboratories (Gurgaon, India) in an all-stock transaction, which has a total equity value of about $3.2 billion. The combination of Sun Pharma and Ranbaxy will create the fifth-largest specialty generics company in the world and the largest pharmaceutical company in India. Ranbaxy shareholders, under the agreement, will receive 0.8 share of Sun Pharma for each share of Ranbaxy. The proposed acquisition has been approved by the boards of directors of Sun Pharma and Ranbaxy as well...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa